Statins and ischemic stroke severity: cytoprotection.

  title={Statins and ischemic stroke severity: cytoprotection.},
  author={Larry B. Goldstein},
  journal={Current atherosclerosis reports},
  volume={11 4},
Cytoprotective or neuroprotective interventions would be of value if they could block the processes leading to delayed neuronal death or if they could delay the period between the onset of ischemia and irreversible necrotic injury, thereby lengthening the period for effective reperfusion therapy. Experimental studies in cell culture systems and laboratory animals show that statins have several potential cytoprotective actions, including promotion of angiogenesis, reduction of clot formation and… CONTINUE READING